CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Propanc Biopharma, Inc.

PPCB
$2MMicro Cap

Next catalyst

Phase 1Feb 1, 2027in 77 days

Phase 1 — PRP

Get an email about PPCB's next catalysts

Track Propanc Biopharma (PPCB) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

No other upcoming event in our data.

Catalyst Timeline

1 upcoming, 2 past

Phase 1Next

Phase 1 — PRP

Feb 1, 2027

For advanced solid tumors (pancreatic, ovarian, refractory prostate cancers). Propanc Biopharma announced initiation of a Phase 1b first-in-human study of PRP in February 2027, a multicenter open-label trial enrolling up to 50 patients with advanced solid tumors including pancreatic, ovarian, and refractory prostate cancers.

Source

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical Preparations🇺🇸North AmericaCAMBERWELL, VICTORIA1 employees
Drug Pipeline

No drugs found in this phase.

Frequently asked questions

When is Propanc Biopharma, Inc.'s next FDA catalyst?→

Propanc Biopharma, Inc.'s (PPCB) next tracked catalyst is a Phase 1 readout expected Feb 1, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track PPCB biotech catalysts?→

Add PPCB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Propanc Biopharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply